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Abstract Robotic surgery has emerged as an alternative
option in minimally invasive gynecologic surgery. The
development of the dual-console da Vinci Si Surgical Sys-
tem has enabled modification of the training atmosphere.
We sought to investigate operative times and surgical out-
comes while operating with the dual-console model in a
training environment for our first fifty cases. We identified
the first fifty patients who underwent robot-assisted total
hysterectomy (TRH), with or without bilateral salpingo-
oophorectomy (BSO), with or without pelvic and para-
aortic lymph node dissection (PPALND), by use of the
dual-console robotic system. Records were reviewed for
patient demographics and surgical details. All surgery was
conducted using the dual-console system and performed by
staff physicians and fellows. Operative time was calculated
from robotic docking until completion of the procedure.
Cases were identified from November 2009 through July
2010. Mean age was 56.2 years (SD 13.35, 95 % CI
52.46–59.86). Mean BMI was 29.5 (SD 7.67, 95 % CI
27.35–31.61). Seventy-eight percent of these patients were
considered overweight, including 12 defined as obese (BMI
30–34.9) and 10 patients classified as morbidly obese
(BMI C 35). Surgery completed included PPALND alone
(n = 1); radical hysterectomy (n = 1); TRH only (n = 3);
TRH/BSO (n = 25); and TRH/BSO/PPALND (n = 20).
Mean total operating room time was 188.8 min (SD 55.31,
95 % CI 173.45–204.11). Mean total surgical time for all
cases was 118.1 min (SD 44.28, 95 % CI 105.87–130.41).
Two vascular injuries were encountered, with one requiring
conversion to laparotomy. These results compare favorably
with historically reported outcomes from single-console
systems. Utilizing the dual-console enables use of an inte-
grated teaching and supervising environment without
compromising operative times or patient outcomes.
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Introduction
Robotic surgery has emerged as an alternative option in
minimally invasive gynecologic surgery with increasing
penetration into the world of gynecologic oncology. Mul-
tiple studies have described the feasibility, efficacy, safety,
and adequacy of this approach in managing gynecologic
malignancies [1–4]. The da Vinci Surgical System
(Intuitive Surgical, Sunnyvale, CA, USA) has advantages
over traditional laparoscopic hysterectomy, including
three-dimensional imaging, instruments with wrist-like
range of motion, elimination of the fulcrum effect, and
faster learning [5]. In a recent survey of Society of Gyne-
cologic Oncology (SGO) members, respondents cited an
overall increase in the use of and perceived indications for
minimally invasive surgery in the field of gynecologic
oncology. In addition, 66 % of physician surveyed planned
to increase their use of robotic assisted surgery within the
upcoming year [6].
This manuscript was presented during a poster session at the annual
meeting of The Western Association of Gynecologic Oncologists,
Park City, UT; May 2011.
A. L. Smith (&)  E. M. Scott  T. C. Krivak 
A. B. Olawaiye  S. D. Richard
Department of Gynecologic Oncology, Magee-Womens Hospital
of UPMC, 300 Halket St., Pittsburgh, PA 15213, USA
e-mail: smitha11@upmc.edu
T. Chu
Magee Womens Research Institute, 204 Craft Ave., Pittsburgh,
PA 15213, USA
123
J Robotic Surg (2013) 7:113–118
DOI 10.1007/s11701-012-0348-1
Incorporation of robotics into a training environment has
been difficult because of the one-surgeon and one-surgery
mentality of robotics. Successful training programs have
utilized a process involving progressive involvement of
additional surgeons, fellows, and residents [7]. Reviews
have shown that it can take 20–100 surgeries for a surgeon
to reach stable operating times and surgical proficiency
when utilizing the robot [3, 8–10]. With the release of the
dual-console da Vinci Si Surgical System (Intuitive Sur-
gical) in 2009, a redefinition of the training atmosphere for
new surgeons has emerged. We sought to investigate out-
comes, specifically operative time and surgical outcomes,
while operating with the dual-console model in a training
environment for our first fifty cases.
Materials and methods
After obtaining Institutional Review Board approval, we
retrospectively identified the first fifty patients who
underwent robot-assisted surgery using the dual-console da
Vinci Si Surgical System at Magee-Womens Hospital of
UPMC. No patients were excluded from analysis. Decision
to perform robotic surgery was left to the discretion of the
attending physician and the availability of the robot. This
cohort of patients came from all staff physicians at our
institution trained in use of the robot (SR, TK, and AO).
These physicians were accompanied by the clinical gyne-
cologic oncology fellow assigned to the inpatient service at
the time of this review. All patients gave appropriate
informed consent before the procedure.
The primary endpoint was total surgical time. Addi-
tional endpoints included estimated blood loss (EBL) and
complications. Records were reviewed for patients’ age,
body mass index, pre-operative diagnosis, and procedure.
Surgical time was calculated from robotic docking until
completion of the procedure. EBL was determined by
measurement as documented in the anesthesia records.
All procedures were performed with the dual-console da
Vinci Si Surgical System with two operating surgeons and
at least one bedside assistant. Operating surgeons consisted
of an attending staff physician and a gynecologic oncology
fellow, each at their respective console. A resident physician
was used as bedside assistant during these first cases for
uterine manipulation, suction/irrigation, and specimen
extraction as indicated. Although the staff physicians had
completed the required off-site training and proctored cases
to be certified for use of the robot, the cases identified in this
cohort were the initial cases for each physician. Fellows and
resident physicians had only received in-house training
before assisting with the surgery.
The robotic surgical technique used is similar to that
found on the Intuitive Surgical Instructional website for
robotic hysterectomy. Uterine manipulation was accom-
plished with the V-Care uterine manipulator (Conmed,
Utica, NY, USA). Three 8-mm robotic trochars, a 12 mm
camera port, and a 12 mm bedside assistant port were used.
For the purposes of these procedures, the primary surgeon
controlled two robotic arms, one on either side of midline.
These instruments were the primary operating instruments
for the procedure. The second surgeon controlled the third
robotic arm and assisted primarily with retraction and
manipulation of the uterus with a da Vinci Prograsp. Parts
of the surgery were shared between the operating surgeons
at each console.
Before surgery all patients underwent mechanical bowel
preparation and received appropriate pre-operative antibi-
otics. DVT prophylaxis consisted of intra-operative pneu-
matic compression stockings and post-operative Enoxaparin
therapy. All patients were admitted after their surgery for
inpatient observation. Complications were recorded up to
90 days post-operatively.
Characteristics of the study population and study end-
points were analyzed and described by use of the usual
statistics: mean with standard deviation and 95 % confi-
dence intervals (CI). All 95 % CIs for proportions were
estimated using the exact binomial distribution. Linear
regression analysis was used to examine associations
between several variables and case number performed.
Cases were identified in the order which they were per-
formed, cases one through fifty.
Results
Of the fifty patients included in this study, the mean age
was 56.2 years (SD 13.35, 95 % CI 52.46–59.86). Mean
BMI was 29.5 (SD 7.67, 95 % CI 27.35–31.61). Seventy-
eight percent of these patients were considered overweight,
including 12 defined as obese (BMI 30–34.9) and 10
classified as morbidly obese (BMI C 35). Demographic
data are listed in Table 1.
Most of the patients in this cohort were operated on for
endometrial cancer (n = 22), adnexal mass (n = 12), or
endometrial hyperplasia (n = 11). Remaining pre-opera-
tive diagnosis included dysfunctional uterine bleeding
(n = 3) and cervical cancer (n = 2; Fig. 1). Forty-six
patients underwent a robotic hysterectomy with bilateral
salpingo-oophorectomy and three had a robotic hysterec-
tomy alone. Lymphatic staging occurred in 44 % (22/50) of
these patients, including one patient who had an interval
staging for endometrial cancer. Mean total operating room
time (from induction of anesthesia to patient extubation)
for the first fifty cases was 188.8 min (SD 55.31, 95 % CI
173.45–204.11). Mean total surgical time (from robotic
docking to skin incision closure) for all cases was
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118.1 min (SD 44.28, 95 % CI 105.87–130.41). When
cases were classified as benign or malignant, mean surgical
times were 98 min (SD 40.53, 95 % CI 81.43–114.57) and
135 min (SD 40.51, 95 % CI 119.72–150.28), respectively.
Mean estimated blood loss was 108.7 ml (SD 98.32, 95 %
CI 81.45–135.95; Table 2). Mean number of pelvic and
para-aortic lymph nodes removed were 9.3 and 4.6,
respectively. Post-operative diagnosis included benign
disease, Stage IA, IB, and IIB endometrial cancer, Stage IA
ovarian cancer, and Stage IB1 cervical cancer (Fig. 2).
We performed linear regression analysis to study the
effect of experience with the robot on total operating room
time, total surgical time, LOS, and EBL. Given that the






















Dysfunctional uterine bleeding 4
Cervical cancer 2
a Underweight = BMI \20; Normal = BMI 20–24.9; Over-
weight = BMI 25–29.9; Obese = BMI 30–34.9; Morbidly
obese = BMI C 35
b One case was performed for two pre-operative indications. As such,
the total number of pre-operative diagnoses is one greater than the
total number of cases included in the review
c Cases included those performed for known dysgerminoma, known
LMP tumor of the ovary, known ovarian cyst, elevated testosterone
suspicious for tumor of ovarian origin, and other uncharacterized
pelvic masses
d Cases included those performed for endometrial complex atypical
hyperplasia, cervical dysplasia, and post-menopausal bleeding
Fig. 1 Patients’ pre-operative diagnosis
Table 2 Operative results for 50 patients who underwent gyneco-
logic robot-assisted surgery
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data were from our initial incorporation of the dual-console
robotic model, cases were examined in the order in which
they were performed (ex. 1–50) to obtain an estimate of the
progression of our experience with the robot. When con-
trolling for age, BMI, and pre-operative diagnosis, case
number is a significant predictor, with negative coefficients
for total surgical time and total operating room time
(p = 0.007 and 0.0018), respectively. Case number was
not associated with LOS (p = 0.3) or EBL (p = 0.56).
These findings provide evidence that there was improve-
ment in proficiency as operators were familiarized with the
techniques and procedures.
Intra-operative complications included two vascular
injuries, one of which required conversion to laparotomy
for repair of bleeding from the external iliac vein. Neither
vascular injury was a direct result of a component of the
surgery performed from the dual-console, but rather
bleeding encountered during normal lymphatic dissection.
Post-operative complications included seven wound
infections, two vaginal cuff complications, two ureteral
obstructions, and one pulmonary embolism (Table 3).
Detection of the first ureteral complication was noted intra-
operatively at the time of cystoscopy. Bilateral ureteral jets
were noted; however there was a decreased flow on the left.
This patient was managed by urology with ureteral stent
placement for four weeks and had no residual problems
after stent removal. The second ureteral injury was noted
one week post-surgery when the patient returned with flank
pain and an abdominal fluid collection. On imaging,
extravasation of contrast was noted and ureteral necrosis
was identified on a ureteroscope by urology. The patient
underwent percutaneous nephrostomy tube placement with
subsequent neo-ureterocystostomy six months after the
original surgery.
Discussion
The 21st century brought with it a movement toward
minimally invasive surgery in gynecology and gynecologic
oncology. The ultimate objective is to maximize those
procedures that can be performed safely and accurately via
a minimally invasive approach. In 2006, the Gynecologic
Oncology Group presented results of a multi-center ran-
domized trial which revealed favorable surgical outcomes
when comparing laparoscopy and laparotomy [11, 12]. As
more physicians utilized laparoscopic surgery, robot-
assisted minimally invasive procedures have emerged and
gained popularity after approval by the Food and
Drug Administration in 2005 for gynecologic procedures
[13, 14].
There is limited published data on the application of
dual-console robotic surgery in gynecology. A recent
publication by Marengo et al. [15] reviewed prospective
data collected on 33 patients undergoing dual-console
robotic surgery for varying indications at their institution.
The authors cited a mean operative time of 152 min and a
mean anesthesia time of 196 min. Although a dual-console
robotic set-up was used, only one of the surgeons in this
review performed the procedure—the other console was
used for observation and verbal assistance. The authors did
not note a statistically significant difference in operating
time between their first 15 and last 18 cases.
Review of additional literature enables us to compare
dual-console procedures with the same or similar proce-
dures completed using a single console. The first report of
TRH was by Diaz-Arrastia et al. [16]. Data published from
this study combined both oncologic and benign procedures.
After stratification of their results the authors reported an
average EBL of 253 ml, average hospital stay of 2.5 days,
and overall incidence of complications of 7.3 % when the
data from all cancer patients were examined. From 2005 to
2007 Boggess et al. [17] reported an average EBL of
74.5 ml, average hospital stay of 1 day, and an average
operative time of 191.2 min for their TRH with staging for
endometrial cancer. In comparison, our operative time for
staging procedures is significantly less at 135 min. In our




Converted to laparotomya 1
Post-operative complications
Wound cellulitis 7
Vaginal cuff complicationb 2
Ureteral obstruction 2
Pulmonary embolus 1
Total (excluding 3 return to OR) 12
a Case converted to laparotomy for repair of vascular injury
b Vaginal cuff complications included hematoma and dehiscence
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review, we specifically report our operative times using the
dual-console for our first fifty cases, benign and malignant.
It should also be noted that at our institution, the dual-
console system is the only system available. Therefore, we
are unable to perform an institutional comparison of single
versus dual-console surgery.
In 2008 a survey of SGO members was performed by
Mabrouk et al. [6], 76 % of respondents reported no or
limited laparoscopic training during their fellowship, and
78 % now believe that maximum emphasis should be
placed on laparoscopic training. When a similar survey was
completed in 2004, only 55 % of respondents noted a high
importance of minimally invasive surgery. From this same
group surveyed, 24 % indicated they performed robot-
assisted surgery. Many gynecologic and gynecologic
oncology surgeons may utilize the dual-console da Vinci
system to overcome the limited experience that clinicians
may have faced during their training or earlier parts of their
careers.
A major hurdle to success in robotic surgery is the
associated learning curve, which applies to both the sur-
geon and the surgical team. Lenihan et al. [18] demon-
strated that the learning curve for benign conditions
stabilized at 95 min after having completed 50 cases.
Similar improvements in operative time have been noted in
gynecologic oncology; however, none of these reviews
evaluated use of the dual-console system [19]. It has been
determined that approximately 20–25 surgical robotic
cases are required to obtain proficiency using this tech-
nique [20, 21]. A recent study by Lim et al. [22] established
that learning how to perform robotic surgery at their
institution required half the number of cases for proficiency
compared with the same cases completed laparoscopically.
This could in part be because of the overall increase in
exposure of physicians to laparoscopy before adopting
robotic surgery. However, the mean operative time in this
study for completion of a TRH/PPLAND was 147.2 ±
48.2 min. The mean operative time differed by only
38.1 min when comparing the surgeons’ times from before
and after their 24th cases. We sought to examine our first
50 cases with reference to the above cited manuscripts
which had previously examined proficiency and learning
curves for robotic surgery. Our study shows that utilization
of the dual-console system gives a second surgeon the
opportunity to gain robotic experience, which in turn may
result in earlier proficiency.
By improving precision and dexterity, robotic technol-
ogy enables the surgeon to perform operations that were
previously not amenable to minimally invasive surgery.
This is especially true for patients that are morbidly obese.
Use of the dual-console robotic system at our institution
has enabled us to develop and optimize techniques and
surgery that are safe, effective, and beneficial to our
patients. It has enabled the development of a training
module that can be used among physicians with different
levels of experience. In our training environment, operating
with the dual-console da Vinci Si is a safe and feasible
option for completion of hysterectomies and staging pro-
cedures. A new teaching paradigm has evolved, providing
trainees with more exposure and experience in robotic
surgeries. Use of the dual-console enables integrated
teaching, surgical cooperation with proctoring, and super-
vision, without compromising operative times or patient
outcomes.
Conflict of interest None.
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